Abstract

Developmental thymic waves of innate-like and adaptive-like γδ T cells have been described, but the current understanding of γδ T cell development is mainly limited to mouse models. Here, we combine single cell (sc) RNA gene expression and sc γδ T cell receptor (TCR) sequencing on fetal and pediatric γδ thymocytes in order to understand the ontogeny of human γδ T cells. Mature fetal γδ thymocytes (both the Vγ9Vδ2 and nonVγ9Vδ2 subsets) are committed to either a type 1, a type 3 or a type 2-like effector fate displaying a wave-like pattern depending on gestation age, and are enriched for public CDR3 features upon maturation. Strikingly, these effector modules express different CDR3 sequences and follow distinct developmental trajectories. In contrast, the pediatric thymus generates only a small effector subset that is highly biased towards Vγ9Vδ2 TCR usage and shows a mixed type 1/type 3 effector profile. Thus, our combined dataset of gene expression and detailed TCR information at the single-cell level identifies distinct functional thymic programming of γδ T cell immunity in human.

Knowledge about the ontogeny of T cells in the thymus relies heavily on mouse studies because of difficulty to obtain human material. Here the authors perform a single cell analysis of thymocytes from human fetal and paediatric thymic samples to characterise the development of human γδ T cells in the thymus.

Details

Title
Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis
Author
Sanchez Sanchez, Guillem 1   VIAFID ORCID Logo  ; Papadopoulou, Maria 1   VIAFID ORCID Logo  ; Azouz, Abdulkader 2   VIAFID ORCID Logo  ; Tafesse, Yohannes 1   VIAFID ORCID Logo  ; Mishra, Archita 3 ; Chan, Jerry K. Y. 4 ; Fan, Yiping 4 ; Verdebout, Isoline 1   VIAFID ORCID Logo  ; Porco, Silvana 1 ; Libert, Frédérick 5 ; Ginhoux, Florent 6   VIAFID ORCID Logo  ; Vandekerckhove, Bart 7 ; Goriely, Stanislas 2   VIAFID ORCID Logo  ; Vermijlen, David 8   VIAFID ORCID Logo 

 Université Libre de Bruxelles (ULB), Department of Pharmacotherapy and Pharmaceutics, Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université Libre de Bruxelles (ULB), Institute for Medical Immunology, Gosselies, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université Libre de Bruxelles (ULB), ULB Center for Research in Immunology (U-CRI), Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746) 
 Université Libre de Bruxelles (ULB), Institute for Medical Immunology, Gosselies, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université Libre de Bruxelles (ULB), ULB Center for Research in Immunology (U-CRI), Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746) 
 Singapore Immunology Network (SIgN), A*STAR, Singapore, Singapore (GRID:grid.430276.4) (ISNI:0000 0004 0387 2429); Telethon Kids Institute, University of Western Australia, Perth, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 KK Women’s and Children’s Hospital, Department of Reproductive Medicine, Singapore, Singapore (GRID:grid.414963.d) (ISNI:0000 0000 8958 3388); National University of Singapore, Experimental Fetal Medicine Group, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Duke-NUS Medical School, Academic Clinical Program in Obstetrics and Gynaecology, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924) 
 BRIGHTcore ULB-VUB, Université Libre de Bruxelles (ULB), Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746) 
 Singapore Immunology Network (SIgN), A*STAR, Singapore, Singapore (GRID:grid.430276.4) (ISNI:0000 0004 0387 2429) 
 Ghent University, Department of Diagnostic Sciences, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798) 
 Université Libre de Bruxelles (ULB), Department of Pharmacotherapy and Pharmaceutics, Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université Libre de Bruxelles (ULB), Institute for Medical Immunology, Gosselies, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Université Libre de Bruxelles (ULB), ULB Center for Research in Immunology (U-CRI), Brussels, Belgium (GRID:grid.4989.c) (ISNI:0000 0001 2348 0746); Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium (GRID:grid.509491.0) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2721078492
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.